The British Institute of Radiology launches new open access AI journal

March 6, 2024

The British Institute of Radiology (BIR), building on its renowned heritage in radiology and radiation oncology, has launched a new open access journal, BJR|Artificial Intelligence. This new journal further builds on the successful portfolio of BIR journals, including flagship journal BJR¸ as well as BJR|Open and BJR|Case Reports.

BJR|Artificial Intelligence is a fully open access, peer-reviewed journal dedicated to artificial intelligence in medical imaging, radiotherapy, radiation oncology, medical physics, radiobiology and the underpinning sciences. Led by Founding Co-Editors-in-Chief Professor Heang-Ping Chan and Professor Issam El Naqa, and supported by a large international Editorial Board of experts in AI, the journal welcomes submissions across the journal’s scope and considers the following article types:

Original research
Systematic Review
Review
Pictorial Review
Opinion
Technical Implementation
Data Resources for AI
Guidelines and Recommendations
Practice and Policy

Professor Issam El Naqa said “This is an extremely exciting project for the BIR and I am delighted to be part of it. I look forward to seeing the journal grow and evolve over the years, providing an impactful contribution to AI research within the field of radiology and radiation oncology”.

The journal opened for submission in October 2023, and has published its first volume and issue in March 2024.BJR|Artificial Intelligence will follow a continuous publication model, whereby one volume and issue are published each year. All published content will be published under an open access CC BY licence, meaning the articles are free to all to read, share and reuse, as long as appropriately attributed.

Professor Heang-Ping Chan said “BJR|Artificial Intelligence will be a home for innovative and original AI work in radiological sciences, including contributing to its successful and safe implementation in clinical practice. We envision that the journal will play a key role in advancing AI in healthcare.”.

Clarivate Top 100 Global Innovators 2024 list released today

March 6, 2024

Clarivate Plc a leading global provider of transformative intelligence, today revealed its 2024 list of Top 100 Global Innovators™ – organizations leading the world in technology research and innovation. For the first time, Clarivate ranked the top 100 organizations to provide a more defined view, as competition for exceptional patentable ideas grows more intense.

New this year: This year, Clarivate is revealing the Top 100 Global Innovators 2024 ranking. The Top 100 Global Innovators are performing well above all other innovators globally. Each of these companies and research institutions have invested in innovation with conviction and consistency. Their work crosses disciplines and industries, and shapes future direction.

Geographical spread: Ten countries and regions are identified in this year’s list – two less than last year. Japan maintains its position as the biggest contributor of Top 100 entities with 38 organizations named followed by the United States with 17, two less than in 2023. Asia continues to extend its leadership in the global innovation ecosystem with 62 organizations listed in 2024, four more than in 2023. Taiwan has 11 organizations named, South Korea has eight, three more than in 2023, and Mainland China five, one more than last year. In Europe, Germany has seven organizations named, France has six, Switzerland has four, Netherlands has three and Sweden has one.

Industry sectors: Industrial segments have increased representation in this year’s list, a trend seen in last year’s report. Industrial systems saw a significant increase (+4) alongside Semiconductors (+2) and Software, media, and fintech (+1). However, momentum has not been uniform, with decreases observed across several segments this year. Chemicals and materials declined (-3), as did Industrial conglomerates (-2).

Gordon Samson, President, Intellectual Property, Clarivate, said, “To feature as a Top 100 Global Innovator is no mean feat as maintaining an edge in the innovation ecosystem is harder than ever. Organizations must balance experimentation and risk with discipline and reward. We measure and rank innovative performance in a dynamic and thorough way, using live thresholds of differentiation. At Clarivate, we think forward by analyzing the quality of ideas, their potency and their impact to identify the world’s top innovators, and this year we’re revealing the ranking of these innovators for the first time.”

Other key findings from the 2024 report include:

Two companies awarded Top 100 status for the first time: Taiwan electronics company Coretronic and Japan precision tool manufacturer Disco.
Three companies re-enter the Top 100: Tencent, Daikin Industries, and Zeiss.
18 all-time recipient organizations retained Top 100 Global Innovator status: Samsung Electronics, Honda, Toyota, GE, LG Electronics, Panasonic, Sony, Hitachi, Toshiba, Ericsson, Qualcomm, Dow, Fujitsu, Boeing, Shin-Etsu Chemical, Honeywell, NEC, and Roche.
A look at the bigger picture, based on the Top 1,000 entities, suggests continued growth in the Asia-Pacific region. Innovators in Mainland China, Taiwan, Japan and South Korea are predicted to improve their average rankings.
Based on predictions from the Top 1,000 organizations, the government and academic research segment will significantly contribute to applied innovation.

To build the Top 100 Global Innovators 2024 report, the Clarivate Center for IP and Innovation Research™ measures the quality of ideas, their potency and their effect. To achieve this, we combine modern analytical architecture with over 60 years of experience from Derwent World Patents Index™ (DWPI™) and Derwent Patent Citation Index™.

Learn more about Top 100 Global Innovators 2024 here.

Collaboration essential to meet open data challenges, says new report

March 6, 2024

A new report – part of The State of Open Data series – provides real-world insights into how the research community is responding to the challenges of data sharing, including support needed for researchers and the importance of building a stronger collaborative approach to open data and research.

From theory to practice: Case studies and commentary from libraries, publishers, funders and industry has been published by Digital Science, Figshare and Springer Nature, following on from the release of their State of Open Data Report 2023 and its key recommendations.

From theory to practice is the first time in the nine-year history of The State of Open Data that a supplementary publication has expanded upon the main report’s years of survey results about open data, involving tens of thousands of researchers globally.

Each case study and commentary is told from the perspective of a research stakeholder group:

Funding bodies: The NIH Generalist Repository Ecosystem Initiative: meeting community needs for FAIR data sharing and discovery
Scholarly Publishers: Operationalize data policies through collaborative approaches – the momentum is now
University Libraries: One size does not fit all: an investigation into how institutional libraries are tailoring support to their researchers’ needs
Industry: How Open Pharma supports responsible data sharing for pharma research publications.

The authors of From theory to practice include representatives from the National Institutes of Health (NIH) – the largest public funder of biomedical research in the world – and NIH Office of Data Science Strategy, writing alongside publishers such as Wiley, Elsevier, Taylor & Francis, and STM Publishing Group, academic institutions the University of Oxford, Leeds Beckett University, University of Sheffield, Graz University of Technology, Northwestern University, as well as Oxford PharmaGenesis, and many others.

A key theme of the report is that collaboration is critical to supporting researchers, promoting data sharing and fostering open research. Such an example is the NIH Generalist Repository Ecosystem Initiative (GREI), bringing together generalist data repositories in a kind of “coopetition” but with a consistent, cohesive approach that benefits researchers.

Another collaborative approach is highlighted by Open Pharma – a member-led, non-profit, multi-sponsor collaboration – which states clearly its aim to build even stronger partnerships in the hopes of ensuring that pharma-sponsored published research is transparent, accountable, accessible and discoverable.

Mark Hahnel, VP Open Research at Digital Science and founder of Figshare, says: “By sharing their case studies, the authors of From theory to practice enhance the experience of The State of Open Data 2023’s key findings and recommendations. Here we see how some of those recommendations are being put into practice, and the effort being made to ensure open research has a robust, meaningful, sustainable, and impactful future.”

Graham Smith, Open Data Programme Manager, Springer Nature, says: “The State of Open Data 2023deliberately took a more analytical approach to the survey data than in previous years. Our new report – From theory to practice – provides essential context from key stakeholder groups within our research community. These case studies are a strong illustration of open research implementation, giving us greater insight into how to best support global researchers in the adoption of open science practice.”

The full report, From theory to practice: Case studies and commentary from libraries, publishers, funders and industry, can be found on Figshare: https://doi.org/10.6084/m9.figshare.25232899

Sony, jointly with Nature, launches new award to recognise the work being done by women in technology

March 6, 2024

Sony Group Corporation (Sony) and Nature have partnered to launch the “Sony Women in Technology Award with Nature.” The inaugural award, open for applications from today, will recognise three outstanding early to mid-career women researchers in technology (including science, engineering, and mathematics) whose work is driving a positive impact on society and the planet.

With women comprising less than a third of technology roles in the global workforce, Sony and Nature will use this award to champion promising women researchers during crucial phases in their research and career development. The winners of the award will be announced in early 2025. All three winners will each receive a prize of $250,000 U.S. Dollars to support and accelerate work related to their research, and a chance to showcase their research work and achievements on nature.com.

Speaking of the awards Hiroaki Kitano, Senior Executive Vice President and CTO, Sony Group Corporation commented:

“At Sony, we build technology for creators. We believe that creators are not just artists, but also scientists and engineers – people who are actively working to build an inspiring future. Technological breakthroughs and innovations to make them work in the real world, solving problems, and exploring new opportunities call for the highest level of creativity. To achieve this creativity, diversity of expertise and experiences is essential. We are excited to launch the “Sony Women in Technology Award with Nature” to support outstanding female researchers at a critical stage in their careers and delighted to work with Nature on this important initiative. We are thrilled to launch this program as part of our broader endeavour across Sony to support diversity in creative and technical fields.“

Magdalena Skipper, Editor in Chief, Nature added:

“Research and technology have a key role in setting the agenda in how to address and tackle some of our world’s most pressing challenges. Yet, of those who pursue research as a profession, only around 30% are women, and when it comes to technology, women are less than a fifth of those currently working in this sector. It should be everyone’s responsibility to support women in research and technology. Their contributions bring much-needed diversity and inclusion and deserve to be celebrated. If we are to see a technology sector that continues to innovate and think creatively, we need more women in active research and engineering. At Nature, we are in a unique position to help support that change. Through this new award with Sony, we can provide a global platform to celebrate the work of emerging women researchers and engineers who may otherwise go unheralded. Women who, through their work, are driving positive change for the planet and society need new opportunities to showcase their work and be awarded for it.”

Applications for the award will be accepted from March 6 through May 31, 2024. Submissions will be evaluated by a judging panel of independent, esteemed technologists, scientists and experts from across the globe, including Nature Editor-in-Chief, Dr. Magdalena Skipper as well as Dr. Hiroaki Kitano, CTO of Sony Group Corporation. Each application will be judged on the merits of ambition, innovation, conceptual excellence, impact and social significance.

For more information about the award, as well as full submission guidelines and criteria, please visit:

https://womenintechnology.sony.com.

To hear more about the impact and aim of the award, click here for a video message from Hiroaki Kitano’s and here for a video message from Magdalena Skipper.

New AI-powered summarization launched for Dimensions

March 6, 2024

Digital Science is delighted to announce the launch of AI-driven summarization in Dimensions, a new feature to support the user in their discovery process for publications, grants, patents and clinical trials.

Dimensions, the world’s largest collection of linked research data, continues to move forward with AI-related functionalities, deployed to robustly support users and their research. Digital Science is today announcing it has integrated AI-driven summarization capabilities into the Dimensions web application to enable all users to accelerate the identification of the most relevant content for their research questions. The short, concise summaries are available for every record in a given search result list with just one click, quickly providing the user with AI-generated insights to help them discover more.

Today’s announcement follows last week’s release of Dimensions Research GPT and Dimensions Research GPT Enterprise on the OpenAI ChatGPT platform. While the Dimensions GPT products are only available to ChatGPT clients, the new Dimensions summarization feature is available on all Dimensions versions immediately – even the free web app.

Originally launched in beta as an AI Assistant in August 2023, the Dimensions team has used feedback from members of the research community – including academic institutions, industry, publishers, government, and funders – to develop an updated, fully integrated summarization feature in the Dimensions web app.

The summarization tool is the latest in a number of AI-driven innovations from the Dimensions team, complementing the launch of Dimensions Research GPT on 28th February. Their approach to the responsible development of AI tools is designed to harness the power of AI, grounded in scientific evidence from the academic record.

A key challenge faced by researchers and industry globally includes the difficulty of wading through the sheer volume of content available – Dimensions shows that over seven million articles, patents and grants were published in 2023 alone – as well as the time taken to understand what they mean for any given research project. With document-level summarization, an instant AI-generated summary can be created for any of those publications to gain an immediate insight into what’s most relevant to a user’s research area.

Digital Science CEO Daniel Hook said: “The launch of publication summaries in Dimensions represents Digital Science’s wider commitment to innovation, hand-in-hand with the responsible development of AI tools.

“Dimensions’ new summarization feature provides all users – whether they are customers of our enhanced platform or accessing it via our free web app – an effective way to discover and quickly evaluate the relevance of research publications. We think this new feature is an important new step in harnessing the capabilities of AI in a way that not only provides equitable access to the newest technologies to all researchers, but one which continues to place humans at the center of the research experience. This release introduces AI as a tool to enhance a user’s capability on the Dimensions platform in a fully integrated way – but just one step of many in the future.”

De Gruyter Brill begins here

March 4, 2024

De Gruyter and Brill have joined forces to form De Gruyter Brill, a leading academic publisher in the humanities and beyond. To mark the occasion, a new corporate website has been launched today at degruyterbrill.com.

With combined pro forma revenues of approximately €140 million and 750 employees, De Gruyter Brill is uniquely positioned to offer outstanding services and technological infrastructure tailored to the needs of academic authors, librarians, and institutions around the world. Together, De Gruyter Brill publishes well over 3,500 books and 800 journals per year, with a particularly strong focus on the humanities and social sciences, while extending to subject areas in science, technology, engineering, and mathematics.

The increased scale not only enables De Gruyter Brill to offer a highly attractive and diverse publishing environment for its authors’ publications across disciplines. It also allows the publisher to accelerate the transition to open access and fund technology investments for the benefit of the scholarly community. Joining forces also makes the business more resilient, allowing more effective sales and marketing operations and increasing the ability to attract and retain talent.

The new name De Gruyter Brill signals the importance of the long heritage of both publishers. The existing individual De Gruyter and Brill brands, as well as their respective imprints and publishing programs, will continue. De Gruyter Brill intends to build on the size, breadth, and depth of the existing publishing programs, offering authors as many opportunities to publish under established De Gruyter Brill imprints, in existing series and journals, and in as many subject areas as before.

As scholarly publishing continues to digitize and move toward open access, operational scale has become an increasingly important factor in remaining competitive, funding future investments, and achieving efficiencies. The strategic rationale is underpinned by shared cultural values. De Gruyter and Brill are deeply rooted in the scholarly community, building on a long tradition of trusted partnerships with academic institutions, serving authors, and publishing research of the highest quality.

“The creation of De Gruyter Brill is an exciting new chapter in the centuries-long history of our two publishing houses,” said Carsten Buhr, Chief Executive Officer of De Gruyter Brill. “I firmly believe that as De Gruyter Brill we will be in an even better position to shape the future of scholarly communication as a trusted partner to the academic community. I look forward to working with our new and existing colleagues to ensure that rigorous scholarly research continues to have a significant impact on the world.”

“As De Gruyter Brill, we will be able to provide better services, technology, and infrastructure to our authors and the academic community at large. In addition, we will accelerate our transition towards open access. The research we publish is crucial in answering today‘s global questions and, as the leading publisher in the humanities, we will be able to increase its impact,” said Jasmin Lange, Chief Publishing Officer, De Gruyter Brill.

“With the creation of De Gruyter Brill we are bringing Brill back into family ownership. Our independence will allow De Gruyter Brill to prioritize long-term investment and economic sustainability. We are committed to ensuring that De Gruyter Brill remains a family-owned, independent publishing house for many more centuries to come,” said Rüdiger Gebauer, Chairman of the Supervisory Board of De Gruyter Brill.

With the closing of the transaction, Brill’s delisting from Euronext will come into effect on 28 March 2024.

Jisc, UK institutions, and Wiley renew open access agreement

February 28, 2024

Wiley, a global leader in research and learning, has renewed its “read and publish” transitional agreement (TA) with Jisc, which offers researchers at UK universities open access (OA) publishing in all Wiley journals at no cost to them.

The renewed agreement provides unrestricted OA publishing in Wiley’s hybrid journals for eligible authors and includes a “gold fund” for publishing in fully OA journals, calculated to cover all anticipated eligible publishing.

Workflow improvements mean it is easier for authors required to publish under the CC-BY (creative commons attribution) license to comply with their funder’s OA policy.

The deal also continues to provide read access to Wiley’s full journal database and has removed additional fees for upgrades to include new subscription titles.

Caren Milloy, director of licensing at Jisc, says: “This improved agreement means that approximately 10,000 UK research articles can be published immediately OA and be free to reuse. We are pleased that Wiley has responded to sector feedback and agreed to explore some of the questions raised by UK universities during negotiations with Jisc, including ways to improve transparency of publisher offerings and pricing.”

Liz Ferguson, Senior Vice President, Wiley Research Publishing said: “It’s an immense pleasure to build on our years of work with Jisc to make ever-more research open access and to support the thousands of UK scholars in advancing knowledge discovery.”

The new deal is a two-year agreement ending on 31 December 2025, shortened to allow a flexible and dynamic response to the outcome of the Jisc-led critical review of transitional agreements and future requirements for OA agreements in the UK. All Jisc member institutions are eligible to sign up.

Dimensions Research GPT – evidence-based research insights for ChatGPT platform users

February 28, 2024

Digital Science is pleased to announce the launch of two new products – Dimensions Research GPT and Dimensions Research GPT Enterprise – bringing the unmatched, trusted research coverage of Dimensions to the ChatGPT platform.

Users can get AI-generated answers to research-related questions on the GPT platform informed by Dimensions’ huge database, making ChatGPT more research-specific for topic exploration.

Available to users of both the free and paid Dimensions Analytics web application, Dimensions Research GPT and Dimensions Research GPT Enterprise help overcome challenges of sheer volume of content available, time-consuming tasks required in research workflows, and the need for trustworthy AI products.

By delivering a next-generation search experience, the products help users to understand research fields and find literature relevant to complex concepts rather than simple search terms. As such, Dimensions Research GPT and Dimensions Research GPT Enterprise can help researchers accelerate the path to discovery and innovation.

With Dimensions Research GPT, any Plus or Enterprise ChatGPT Store subscriber can gain insight from the tens of millions of Open Access publications available through Dimensions, providing a quick and effective search of open research on the user-friendly ChatGPT platform. Search results include clickable links that take users to Dimensions, where they can learn more about source materials.

Dimensions Research GPT Enterprise is available to mutual ChatGPT Enterprise and organization-wide Dimensions customers, and incorporates insights from all publications, grants, clinical trials and patents within the Dimensions database. Queries such as “tell me about clinical trials for malaria vaccines”, followed by “tell me about the key research articles that underpin these trials”provide answers that come fully linked to the research literature behind the responses, ensuring that researchers can access and check the source of the information.

Organizations keen to tailor Dimensions Research GPT Enterprise to better meet the needs of specific use cases are invited to work with our team of experts to define and implement these. Key features of Dimensions Research GPT Enterprise, available for mutual organization-wide Dimensions and ChatGPT Enterprise customers, include:

Well-structured explanations that help researchers to go deeper into evidence drawn from publication data, clinical trials, patents and grant information
Ability to search licensed literature in a secure manner
Notifications each time content generated is based on data in Dimensions, with references and citation details.

See a video of Dimensions Research GPT in action.

The launch of Dimensions Research GPT and Dimensions Research GPT Enterprise represents Digital Science’s broader commitment to open science and responsible development of AI tools.

Dimensions’ new products mark the latest development from Digital Science companies that harness the power of AI. In 2023 Dimensions launched a beta version of a natural language querying tool with the Dimensions AI Assistant, while ReadCube also released a pilot version of its AI Assistant. Digital Science also completed its acquisition of AI-based academic language service Writefull in late 2023, with 2024 seeing many more AI developments to come.

“Dimensions Research GPT and Dimensions Research GPT Enterprise are transformative tools that have the potential to evolve the capability of scholars to pinpoint material that is relevant to their work with the use of AI,” said Christian Bode, Head of Product at Dimensions. “Powered by the data contained in Dimensions and combined with ChatGPT’s now well-known conversational interface, they give researchers the benefits of Generative AI technology with results based firmly on scientific evidence.”

Digital Science CEO, Daniel Hook, said: “We believe the launch of Dimensions Research GPT and Dimensions Research GPT Enterprise shows our commitment to responsible innovation by enhancing how researchers are able to find evidence that either support or refute their claims. This tool is not simply about answering questions, it is about a new way to explore and find relevant research with greater context.

“The Enterprise solution allows results that can reference data from 350 million publications, clinical trial, grant, and patent records in Dimensions. With research queries returned from such an evidence base, Dimensions’ GPT products lower the risk of AI hallucinations. References to source material embedded in each response also ensures that researchers can not only trust the results, but also verify them.”

Springer Nature’s Transformative Agreement with Lyrasis Champions Equity

February 28, 2024

Springer Nature has reached a new Transformative Agreement (TA) with Lyrasis, a non-profit member organization working globally to serve libraries and other institutions. The four-year deal covers some 120 institutions and includes eight Historically Black Colleges and Universities (HBCUs) benefiting from greater access to articles. In addition, the agreement will allow over 5,000 articles in the Springer hybrid portfolio to be published immediately open access at no cost to eligible researchers.

A welcome development in a well-established relationship, this new TA builds upon prior agreements between Springer Nature and Lyrasis such as the 2021 Open Access (OA) sponsorship partnership for books supporting research and teaching aligned with the Sustainable Development Goals. The HBCUs included in the TA are the result of Springer Nature’s employees deepening existing relationships with HBCU communities in alignment with Springer Nature’s commitment to Diversity, Equity and Inclusion (DEI).

With the goal of involving more HBCUs in the future, those currently covered by the Lyrasis TA include:

Delaware State University
Fisk University
Grambling State University
Kentucky State University
Morehouse School of Medicine
Morgan State University
Texas Southern University
Xavier University of Louisiana

Maria Lopes, Springer Nature’s Vice President of Research Sales for North America, Latin America and the Caribbean said: “We are delighted to build on our long-standing relationship with Lyrasis via this new agreement that will make it possible for authors at 120 institutions to publish their entire output open access. It is via TAs such as this that we can drive equity, increase readership and author visibility, and foster collaborative research that delivers solutions to pressing issues. TAs play a vital role in enabling a transition to open science and with each one, we cement our joint commitment to that goal.”

Marilyn Hendricks, Executive Licensing Manager at Springer Nature, added: “In order to access opportunities, researchers need to be exposed to specific content. Generally speaking, HBCUs have not had such access. This TA is important in allowing these schools to begin building up their publishing impact. It also enables Black college students to have access to the same content as their peers at non-HBCU institutions.”

Celeste Feather, Senior Director of Content and Scholarly Communication Initiatives at Lyrasis, said: “The Springer Nature journals group at Lyrasis includes a diverse array of institutions that are collaborating at scale to support open access publishing. Research institutions, regional universities, liberal arts colleges, medical schools, Historically Black Colleges and Universities, and Minority Serving Institutions have come together in response to the needs of their communities. We are eager to see the impact of their efforts as authors engage with new publishing opportunities.”

The Company of Biologists announce new Read & Publish Open Access agreements with consortia in Canada and China

February 28, 2024

The Company of Biologists is pleased to announce new Read & Publish Open Access agreements with the Ontario Council of University Libraries (OCUL), Canada and the Digital Resource Acquisition Alliance of Chinese Academic Libraries (DRAA) consortium, China.

Corresponding authors at participating institutions in Canada and China can publish an uncapped number of research articles immediately Open Access (OA) in our hybrid journals (Development, Journal of Cell Science and Journal of Experimental Biology) and our fully Open Access journals (Disease Models & Mechanisms and Biology Open) without paying an article processing charge (APC). Researchers at participating institutions also benefit from unlimited access to our hybrid journals, including their full archives dating back to 1853.

Claire Moulton, Publisher at The Company of Biologists, says:

“As a not-for-profit publisher dedicated to supporting the biological community worldwide, we have a long-standing commitment to Open Access publishing. Our journals were the first in the world to be awarded Transformative Journal status by Plan S and the success of our Read & Publish initiative has already driven a significant increase in Open Access research content in our hybrid journals. We welcome our new Read & Publish agreements with the OCUL and DRAA consortia and look forward to working together to promote the growth of Open Access publishing in the biological and biomedical sciences in both Canada and China.”

The Ontario Council of University Libraries (OCUL)

This is the Company’s first consortium agreement in Canada and is available to 21 member institutions. The five-journal agreement runs from 1 January 2024 to 31 December 2026.

Shelly Turner, Head of Sales and Business Development at The Company of Biologists, says:

“We are delighted with our new partnership with the OCUL Consortium which will expand the readership of our content to a wider audience and will allow authors throughout Ontario to be able to publish fee-free Open Access research articles in all five of our journals.”

View participating institutions | Read the announcement online

Digital Resource Acquisition Alliance of Chinese Academic Libraries (DRAA)

DRAA is a large consortium in China and this agreement, which runs from 2024 to 2026, is available to several hundred member institutions. This is the Company’s first consortium agreement in China and Charlesworth, our representative, was influential in helping us establish this agreement.

Michael Evans, CEO, Charlesworth, says:

“Charlesworth is at the forefront of supporting authors and librarians in China by exploring transformational agreements tailored to the Chinese market. We are excited to be working with The Company of Biologists to deliver a new agreement with the DRAA consortia. This agreement, for the first time, gives libraries the flexibility to choose a transformative model that works best for them.”

Sarah Logan, Regional Sales Manager at The Company of Biologists, says:

“We are thrilled to announce a ground-breaking shift towards open science in China as the DRAA consortium becomes the first consortium to adopt our Read & Publish initiative. We are grateful to our exclusive agent, Charlesworth, for their invaluable contributions in bringing this agreement to fruition, and for their commitment to advancing open science within the DRAA consortium. By joining the DRAA consortium’s 5 journal Read & Publish initiative, libraries can empower their researchers to disseminate their research without any financial barriers to publishing Open Access. We encourage all DRAA consortium members to consider joining us in this exciting journey towards a more open and accessible future for research.”

ReadCube Expands Its Award-Winning Literature Management Platform with the Launch of Literature Review

February 28, 2024

Digital Science is pleased to announce that ReadCube, an award-winning leader in literature management and full-text document delivery, has launched a new solution for research-driven organizations – known simply as Literature Review by ReadCube.

Literature Review seamlessly integrates with ReadCube’s premier literature management platform, trusted by over 650 research organizations globally. Known for its best-in-class user experience and robust literature workflows, ReadCube’s newest solution delivers a turnkey end-to-end workflow for teams tasked with monitoring and analyzing published literature related to their company’s drug, device, product, or service.

The current landscape for companies within the pharmaceutical, medical device (MDR), laboratory-developed tests (LDT), in-vitro diagnostics (IVD), and health technology assessment (HTA) sectors has never been more complex. The rapid growth in the volume of scientific and medical publications, coupled with the escalation of regulatory standards across major global markets, including the United States, the European Union, and other international jurisdictions, adds layers of complexity to an already daunting set of tasks. This has prompted teams to critically assess the inefficiency and risk of error inherent to their long-held SLR processes.

Robert McGrath, ReadCube Founder and CEO, said: “The process of conducting systematic literature reviews has traditionally been both time-consuming and manual, despite being such a crucial step in the research process. We’ve developed Literature Review in close collaboration with key customers, bringing user experience and AI automation capabilities to the forefront in one easy-to-deploy solution. We’re proud to provide a fully integrated solution to solve all-too-common workflow strains.”

Whether an organization is conducting Safety Reviews and Comparative Effectiveness Research or gathering Competitive Intelligence, Literature Review by ReadCube streamlines SLR activities across business units, industries and departments. This newly integrated solution enables teams to effectively and efficiently navigate the challenges of increasing literature volumes and regulatory demands, ensuring every review is both comprehensive and compliant.

For more information about Literature Review, see this blog post on the ReadCube website, or visit the Literature Review solution page.

University of Technology Sydney chooses Figshare to drive the discoverability of non-traditional research outputs

February 28, 2024

Figshare, a leading provider of institutional repository infrastructure that supports open research, is pleased to announce that the University of Technology Sydney (UTS) has chosen Figshare to support them in sharing, showcasing and managing their research reports and non-traditional research outputs.

UTS – Australia’s leading technology university – will use its Figshare repository and its integration with the Australian Research Data Commons Datacite DOI minting service to drive the discoverability and increase the impact of their research reports and non-traditional research outputs, which especially assists its applied researchers and creative practitioners.

UTS will benefit from Figshare’s support for over 1200 different file types and unique in-browser preview capabilities, which will enable them to showcase their non-traditional research outputs whilst maintaining best practices for FAIR and open research sharing.

UTS already utilizes Altmetric, Dimensions and Symplectic Elements across their research ecosystem, making Figshare the fourth Digital Science portfolio to partner with the university.

Professor Kate McGrath, UTS Deputy Vice-Chancellor and Vice-President (Research), said: “Digital Science has historically been a great partner for UTS. With the inclusion of Figshare in their portfolio, we immediately have a way to bring to the forefront the body of work that our researchers deliver that has previously been challenging to identify, showcase and gain insights from. To be able to more fully explore the breadth of our research activities and make it more accessible is an exciting prospect.”

Figshare Founder and Digital Science’s VP Open Research, Mark Hahnel, said: “We’re thrilled to partner with the University of Technology Sydney on a Figshare repository for their non-traditional research outputs. It’s exciting to see another leading Australian institution join the Figshare community and commit resources to the sharing, showcasing and management of NTROs, an area of growing importance in open research.’